Gut Microbiota-Derived Extracellular Vesicles in Cancer: Friends or Foes?
Probiotics and Antimicrobial Proteins
Research outputs
مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.
3,288 مُخرَج
Probiotics and Antimicrobial Proteins
Cureus
Protracted bacterial bronchitis (PBB) is a treatable cause of chronic wet cough in children but is frequently missed.Unrecognized children often cycle through repeat asthma treatment, short antibiotic courses that do not address the infection, or open-ended reassurance without further evaluation.This review summarizes the clinical presentation, diagnostic criteria, differential diagnosis, treatment, and follow-up of PBB in children.We conducted a targeted narrative review (PubMed, through September 2026) of clinical trials, longitudinal studies, systematic reviews, and professional-society guidance, distinguishing evidence for antibiotic treatment from limited observational evidence linking recurrent PBB to bronchiectasis.Clinicians should suspect PBB in a child with a daily wet cough lasting more than four weeks and no findings indicating another cause.Resolution after an appropriate antibiotic course supports the diagnosis.Amoxicillinclavulanate remains the usual first-line treatment, typically for two weeks initially, with reassessment and selective extension to four weeks if the child has not cleared.Further investigation is warranted when symptoms persist despite adequate treatment, recurrence is frequent, or specific warning signs appear.In an otherwise typical, treatment-responsive case, bronchoscopy and chest computed tomography (CT) are not routine first steps.Management hinges on recognizing the wet-cough phenotype, giving an adequate therapeutic trial, confirming resolution, and investigating promptly when treatment fails.Antibiotics appear to improve cough resolution, but this rests on a small number of trials with limited certainty, and evidence that treatment itself prevents bronchiectasis remains thin.
Libyan Journal of Medicine · مجلد 21 (1) · 2746284-2746284
This study reports the biosynthesis of a Selenium/Zinc nanocomposite (Se/Zn NC) using a marine bacterial extract from Bacillus rugosus SYG20. FT-IR detected Zn–O stretching vibrations at 614.81, 500.71, and 463.61 cm⁻¹, together with shifts in biomolecule peaks. XRD revealed a hexagonal wurtzite structure with an average crystallite size of 14.9 nm, and UV–Vis spectroscopy gave an optical band gap of 3.46 eV. TEM showed spherical particles of 10–80 nm, while HRTEM lattice fringes and a polycrystalline diffraction pattern matching cubic ZnSe planes confirmed strong interfacial Se–Zn coordination. DLS indicated a hydrodynamic diameter of 87 nm with a polydispersity index of 0.28. EDX confirmed Se incorporation at 7.0 wt% (Zn:Se atomic ratio ≈ 1.6:1). XPS showed Zn in the divalent state and Se bound to the metal centers rather than as elemental selenium, with a Zn 2p binding-energy shift indicating interfacial coordination rather than a native oxide layer. Hemolysis remained below 1.5% even at 1000 μg/mL, and cytotoxicity against WI-38 normal fibroblasts showed a wide safety margin (IC₅₀ = 392.64 ± 4 μg/mL). The nanocomposite exhibited strong antioxidant activity, with IC₅₀ values of 11.85 ± 0.11 μg/mL (DPPH) and 11.46 ± 0.05 μg/mL (ABTS⁺•), reaching 94.4% and 93.9% inhibition, respectively. Anti-inflammatory assays gave IC₅₀ values of 6.67 ± 0.5 μg/mL for COX-1 and 14.12 ± 0.1 μg/mL for COX-2. Protein denaturation was inhibited with an IC₅₀ of 2.04 ± 0.05 μg/mL, nearly matching diclofenac sodium (2.01 ± 0.04 μg/mL). Antidiabetic screening showed α-amylase and α-glucosidase inhibition with IC₅₀ values of 5.24 and 7.84 μg/mL, and 95.4% and 95.7% blockade at 1000 μg/mL. These in vitro findings support the potential of B. rugosus-derived Se/Zn NC against oxidative stress-related metabolic disorders.
Frontiers in Aging Neuroscience · مجلد 18
Tavapadon is an oral, once-daily, non-catechol partial agonist selective for the D1 and D5 dopamine receptors and represents a mechanistically distinct option currently under clinical investigation for Parkinson disease (PD). This narrative review critically evaluates the biological rationale for D1/D5 receptor targeting, the pharmacological and preclinical development of tavapadon, and the accumulating phase 1–3 clinical evidence for its use as monotherapy in early PD and as adjunctive therapy in patients with motor fluctuations, while highlighting remaining evidence gaps and methodological limitations. A non-systematic literature search of PubMed/MEDLINE, Embase, ClinicalTrials.gov , and Scopus (through May 2026) was performed to identify representative and pivotal randomized controlled trials, pharmacokinetic/pharmacodynamic studies, and mechanistic preclinical investigations relevant to tavapadon and D1/D5 receptor agonism; this narrative approach was not intended to be exhaustive or fully reproducible in the manner of a systematic review. Mechanistically, selective stimulation of the direct striatal pathway together with submaximal intrinsic efficacy at the D1 receptor has been proposed, as a mechanistic hypothesis rather than a demonstrated clinical mechanism, to preserve antiparkinsonian benefit while limiting the receptor-signaling intensity implicated in levodopa-induced dyskinesia. In the phase 2 PARKWAY-II study and the now fully published phase 3 TEMPO-1 and TEMPO-2 trials, fixed- and flexible-dose tavapadon produced clinically meaningful improvements in MDS-UPDRS motor scores compared with placebo in early PD, and in the phase 3 TEMPO-3 trial, adjunctive tavapadon significantly increased daily good ON time and reduced OFF time in levodopa-treated patients with motor fluctuations; efficacy in all trials has been demonstrated only against placebo, with no head-to-head data against levodopa or other dopamine agonists. Adverse events were more frequent with tavapadon than placebo (approximately 72–76% versus 55% across TEMPO-2 and TEMPO-3), with nausea, headache, and dizziness the most common; no excess signal of impulse-control disorders relative to placebo was detected over the available 26–27-week controlled treatment period, and no clinically significant QTc prolongation was observed. The 58-week open-label TEMPO-4 extension, now reported in a peer-reviewed AAN abstract publication in Neurology alongside earlier interim conference data, suggests sustained benefit and a stable long-term levodopa requirement, but lacks a randomized control and cannot yet establish long-term safety superiority over existing agents. Tavapadon is a mechanistically novel candidate with preliminary evidence of efficacy; its ultimate clinical utility will depend on head-to-head trials and long-term safety data.
Transplantation Reviews · مجلد 40 (4) · 101059-101059
Tissue and Cell · مجلد 104 (Pt 3) · 104034-104034
Dermatology Reports
Chronic skin diseases such as psoriasis, vitiligo, eczema, and acne can have substantial psychosocial effects beyond physical symptoms. Visible dermatological conditions often lead to stigmatization, which may negatively influence social interactions, emotional well-being, and quality of life. However, limited research has examined perceived stigmatization among patients with chronic skin diseases in the Eastern Province of Saudi Arabia. This study aimed to quantify and compare perceived stigmatization among patients with chronic skin diseases and identify demographic and clinical factors associated with stigma severity. A cross-sectional study was conducted among 446 patients with chronic skin diseases. Data were collected using a structured questionnaire, including sociodemographic characteristics, clinical information, and the 6-Item Stigmatization Scale. Descriptive statistics were used to summarize participant characteristics. Independent t-tests, one-way analysis of variance (ANOVA), and multivariable linear regression analysis were performed to examine associations between stigma scores and demographic and clinical variables. A total of 446 participants were included, with females comprising 264 (59.2%) and most aged 18-40 years (291, 65.2%). Vitiligo (114, 25.6%) and psoriasis (102, 22.9%) were the most common conditions. Many participants reported stigma-related experiences, including feeling unattractive sometimes or very often (326, 73.0%). Stigma scores were significantly higher among males than females (8.12±3.93 vs. 7.03±4.73, p=0.011) and varied by monthly income (p<0.001). Stigma also differed across disease types (p<0.001), with the highest scores among vitiligo patients (8.74±3.98). In regression analysis, gender (B=1.039, p=0.016), age at disease onset (B=0.052, p=0.002), disease duration (B=-1.268, p=0.003), and family history (B=1.825, p<0.001) were significant predictors of stigma. To conclude, stigmatization is a common psychosocial burden among patients with chronic skin diseases. Addressing stigma through patient support, public education, and integrated psychological care may help improve the well-being of affected individuals.
Scientific Reports · مجلد 16 (1)
Abstract Distributed authentication techniques enable edge device trust in smart manufacturing and energy infrastructure Industrial Internet of Things contexts. Existing blockchain-based authentication schemes mostly use the elliptic curve digital signature algorithm, which can be exploited by quantum adversaries using harvest-now, decrypt-later attacks to record authenticated communications for cryptanalysis. CIPHER-QNL, a post-quantum federated authentication framework, integrates three complementary mechanisms: (1) FALCON threshold signature aggregation with federated polynomial key sharding over NTRU lattice rings for distributed multi-party authentication without centralized private-key exposure; and (2) zk-STARK-based privacy-preserving verification for blockchain consensus authentication proof validation without credential disclosure. Through threshold confidentiality, reduction-based reasoning, and computational complexity analysis, the proposed framework’s security is assessed under Module-SIS and NTRU lattice hardness assumptions. Controlled harvest now, decrypt adversarial authentication scenarios are used to evaluate TON-IoT communication performance. Scalable, privacy-preserving, post-quantum authentication for distributed Industrial Internet of Things environments is shown by 99.1% authentication integrity, 98.7% threshold signature aggregation latency reduction, and 0.29% false rejection rate.
Journal of Molecular Structure · مجلد 1382 · 147801-147801
Frontiers in Cellular and Infection Microbiology · مجلد 16 · 1847743-1847743
Background Carbapenem-resistant Gram-negative bacilli are an increasing threat in diabetic foot ulcer (DFU) infections, limiting therapeutic options and worsening outcomes. However, data linking specific carbapenemase genes to clinical and metabolic factors remain limited. Objectives To isolate Gram-negative bacilli from deep tissue biopsies of DFUs, determine carbapenem susceptibility by minimum inhibitory concentration (MIC) testing, detect major carbapenemase genes by multiplex qPCR, and evaluate their association with glycemic control and Wagner grade. Methods This cross-sectional study included 150 patients with infected DFUs. Isolates recovered from tissue and other specimens were identified by standard microbiological methods, and carbapenem susceptibility was assessed by MIC testing. Multiplex qPCR was used to detect bla KPC, bla NDM, bla OXA-48, bla VIM, and bla IMP, and associations between resistance determinants and clinical variables were analyzed statistically. Results The mean patient age was 56.4 ± 9.8 years, with a male predominance (61.3%), and high-grade ulcers (Wagner III–V) were present in 54.7% of patients. Klebsiella pneumoniae predominated (60.0%), followed by Pseudomonas aeruginosa and Escherichia coli (each 14.7%). Resistance to meropenem and imipenem was high (77.3% and 75.3%, respectively), and carbapenemase production was detected in 84.0% of isolates. bla KPC (28.0%) and bla NDM (24.0%) were the most prevalent genes and were significantly associated with phenotypic carbapenemase production (P = 0.002 and P = 0.006, respectively). Carbapenemase producers showed significantly higher fasting glucose and HbA1c levels than non-producers (P < 0.001), with no significant association observed for Wagner grade (P = 0.570). Conclusions DFUs showed a high burden of carbapenemase-producing Gram-negative bacilli, driven mainly by bla KPC and bla NDM. Poor glycemic control was strongly associated with these resistant infections, underscoring the need for integrated metabolic management, molecular surveillance, and antimicrobial stewardship. These findings position glycemic control as a modifiable driver of antimicrobial resistance in DFUs.
Scientific Reports · مجلد 16 (1)
The molecular axis underlying the epidemiologically established association between periodontitis and coronary heart disease (CHD) remains undefined at mechanistic, systems-level resolution. Classical comparative transcriptomics captures correlational gene lists but cannot reconstruct directional disease-state dynamics or locate the point along a disease-state ordering at which inflammatory resolution fails. ReNODE-Ferro integrates three public bulk transcriptomic datasets (GSE16134, periodontitis, n = 310; GSE28829, CHD staged, n = 29; GSE100927, CHD plaque, n = 104) through a nine-module biologically curated feature space (123 genes), a fully connected latent encoder, a Neural Ordinary Differential Equation (latent dim = 12) learning continuous disease-state dynamics across six biologically defined states (S0–S5), and a model-based reinforcement learning (RL) controller identifying optimal biological intervention policies in latent space. Twenty-four genes were concordantly dysregulated (FDR < 0.05) across all three datasets. Cross-disease fold-change concordance was significant (Spearman r = 0.473, p = 3.29 × 10 − 8, periodontitis vs. CHD staged). Ferroptotic vulnerability and coronary coupling co-varied with r = 0.830 ( p = 3.89 × 10 − 114). Neural ODE tipping-point analysis identified the S2→S3 metabolic strain-to-ferroptosis-primed transition as the transition carrying the highest modelled velocity, although under a held-out validation scheme the velocity profile proved comparatively flat and the location of the maximum unstable across bootstrap refits. S2 was the least responsive state to single-step intervention (3.7%), but it contains only six specimens and was the least stable cluster on resampling. RL policy optimization identified antioxidant restoration, mitochondrial quality enhancement, and pro-resolution amplification as the universal intervention triad (mean reward improvement = 0.583). Robustness analyses added at revision support and delimit these findings. Tissue of origin explained no measurable variance in the nine-module space (PERMANOVA R² < 0.001, p = 1.00) whereas disease status explained 14.0% ( p < 1 × 10⁻⁴), and the ferroptotic vulnerability–coronary coupling association persisted after adjustment for estimated cellular composition (ρ = 0.764) and within every cohort analysed separately (ρ = 0.77–0.89). An independent diffusion-pseudotime ordering reproduced the state sequence (ρ = 0.872) and placed S2 before S3 ( p = 2.4 × 10⁻¹⁰), and leave-one-cohort-out re-derivation recovered the same structure in all three folds. Against 5,000 size-matched random gene panels the curated feature space was strongly informative (empirical p = 2.0 × 10⁻⁴), although an uncurated transcriptome-wide analysis showed the ferroptotic axis to be one of several concordant programmes rather than a uniquely dominant one. Periodontitis and coronary atherogenesis share a conserved ferroptotic-metabolic resolution failure trajectory. ReNODE-Ferro provides a mechanistically grounded, interventionally actionable map of this continuum, establishing ferroptotic vulnerability as a principal and unusually tightly coupled molecular axis of this shared programme. Because all three cohorts are cross-sectional, the reconstructed trajectory is a statistical ordering rather than a demonstrated temporal or causal sequence.
Tissue and Cell · مجلد 104 (Pt 3) · 104020-104020
Scientific Reports · مجلد 16 (1)
Abstract We aimed to assess the prevalence of gastroesophageal reflux disease (GERD) among medical students in Middle East countries and its associated risk factors. A multinational cross-sectional study was conducted among medical students in 8 Middle East countries. GERDQ and GERD-HRQL were used to assess the prevalence of GERD and its HRQL, while DASS-21 was used to assess psychological conditions. A multivariate linear regression model and a multivariate logistic regression model were used to assess the risk factors for GERD and confounders that affect GERD-HRQL. 5994 participants participated in the study, with a mean age of 22.8 ± 2.4, and 58.59% were female. The prevalence of GERD was estimated to be 37.2% (30% had a 79% likelihood of having GERD, and 7.2% had an 89% likelihood of having GERD). Egyptian medical students, followed by Saudi Arabian students, had the highest prevalence, while Palestinian were the lowest. Increasing age and male gender were associated with increased GERD levels. Having coffee or spicy food was associated with increased GERD; coffee drinking was associated with its reduction, while psychological conditions or other eating behaviors were not contributors to an increase in GERD level. Several studies are needed to further assess the association between GERD and risk factors affecting its increase.
— · مجلد 3 (4)
Hip fracture produces severe acute pain and complicates emergency assessment and transfers. Regional nerve blocks provide targeted analgesia within multimodal treatment. This review compared ultrasound-guided techniques for adults receiving emergency department care. PubMed, Scopus, Web of Science, and Cochrane CENTRAL were searched through 31 May 2026. Two authors independently screened studies and extracted data. Randomized trials comparing emergency department initiated single-injection blocks with another ultrasound-guided block, placebo, or systemic analgesia were synthesized narratively. Fourteen randomized trials evaluated femoral, fascia iliaca, and pericapsular nerve group blocks. Femoral blocks generally improved analgesia and reduced opioid exposure relative to systemic treatment, with neutral findings in one short-term fentanyl comparison. Femoral and fascia iliaca blocks produced similar pain reductions in a direct comparison. Supra-inguinal fascia iliaca block improved movement pain relative to the classical approach. Pericapsular nerve group block improved early pain relief relative to infra-inguinal fascia iliaca block and reduced rescue analgesia relative to sham. Opioid reduction varied across trials, including a fascia iliaca study reporting identical median six-hour morphine consumption. Ultrasound-guided blocks improve early hip fracture analgesia in emergency care. Technique selection depends on comparator, assessment timing, and patient characteristics. Data supports regional analgesia within multimodal pathways, without establishing one universally superior block.
— · مجلد 3 (1)
Background: Emergency discharge is an established option for selected adults with uncomplicated acute diverticulitis. Treatment failure is difficult to predict accurately. This focused review examined baseline clinical, laboratory, and computed tomography predictors alongside outpatient outcomes. Methods: Original studies published through 31 May 2026 were examined for computed tomography confirmation, outpatient management, and subsequent deterioration. Ten outpatient studies were summarized descriptively. Broader prognostic cohorts were considered separately because their populations and outcomes differed from immediate emergency discharge. Results: Selected outpatient cohorts recorded low admission rates, including 2/70, 3/66, 4/155, and 4/140 patients in four studies. A randomized outpatient trial recorded hospitalization in 8/242 participants without antibiotics and 14/238 receiving antibiotics. Persistent pain and oral intolerance accounted for several treatment escalations. Imaging associations were imprecise and differed between studies. Different outcome definitions and follow-up periods restricted comparisons of failure frequencies across treatment protocols. Broader cohorts identified free fluid, female sex, elevated C-reactive protein, systemic comorbidity, vomiting, and prolonged symptoms as prognostic signals. Conclusions: Outpatient outcomes were better after structured selection and follow-up. Inflammatory burden, imaging abnormalities, and symptom persistence warrant particular attention. The data supports individualized assessment rather than a universal discharge score, with explicit separation of readmission, complicated progression, and recurrent episodes when interpreting treatment failure across different clinical settings.